Completed study

Official Study Title
A randomized Clinical Trial for enhanced trained Immune responses through bacillus calmette-guérin VAccination to prevenT infections of the Elderly (ACTIVATE)

Brief Description
ACTIVATE is a randomized clinical trial aiming to investigate if the developing concept of trained immunity i.e. the memory of the innate immune system coming after vaccination exists in humans and may lead to protection from infections.

Status: Completed
Study Type: Interventional (Clinical Trial)
Study phase: IV
Study sites: 1 site in Greece
Actual enrolment: 200 participants Identifier: NCT03296423
EudraCT number: 2017-000596-87
National Organization for Medicines Approval: IS024-17
National Ethics Committee Approval: 27/17

Study Start: September 2017
Study Completion: November 2020

Condition/Disease studied: Infection; Hospitalization; Mortality
Keywords: BCG vaccination

Related publications